.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Remedi's performance across various categories in Illinois has shown notable trends. In the Capsules category, Remedi maintained a steady 6th position from April to June 2024, indicating consistent performance despite a slight drop in sales from April to June. In the Tincture & Sublingual category, Remedi demonstrated resilience by bouncing back to the 3rd position in June after slipping to 4th in April and May, with a significant increase in sales. Conversely, Remedi's ranking in the Concentrates category saw a positive upward trend, improving from 24th in March to 18th in June, reflecting a substantial growth in sales during this period.
In Massachusetts, Remedi's performance in the Concentrates category also showed promising progress. Despite not being in the top 30 in March, the brand climbed to the 28th position in April and continued to improve, reaching the 20th position in June. This indicates a growing presence and acceptance of Remedi's products in the market. The significant sales increase from March to June supports this upward trajectory. However, it's important to note that Remedi did not make it into the top 30 brands in some other categories, which may suggest areas for potential improvement or different market dynamics in those segments.
Competitive Landscape
In the Illinois concentrates market, Remedi has shown a notable upward trend in rank and sales over recent months. Starting at rank 24 in March 2024, Remedi climbed to rank 18 by June 2024, indicating a positive trajectory. This improvement is particularly significant when compared to competitors like FloraCal Farms, which fluctuated between ranks 15 and 21, and Verano, which remained relatively stable but lower in sales. Additionally, Avexia and Amber experienced more volatility in their rankings, with Amber making a notable jump from rank 27 in May to rank 16 in June. Despite these fluctuations, Remedi's consistent improvement in both rank and sales suggests a strengthening market position, potentially driven by increased consumer preference or effective marketing strategies.
Notable Products
In June 2024, the top-performing product from Remedi was Indica Rest RSO Dropper (0.5g) in the Concentrates category, maintaining its number one rank with sales reaching 2870 units. The Indica Relief RSO Syringe (0.5g) also held steady at the second position with notable sales of 2420 units. The CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) moved up one rank to third place with sales of 791 units, showing a significant improvement from previous months. Indica Rest RSO Syringe (0.5g) dropped to fourth place despite an increase in sales to 751 units. The CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) remained consistent at the fifth rank with sales of 588 units.
Top Selling Cannabis Brands
